精選文獻回顧及新聞稿

  • behavioural activation
    How well does behavioural activation therapy work for depression in adults?  And what about the effects of this treatment on depression for adults with long‐term physical conditions? Two Cochrane systematic reviews look at the available evidence. Depression is a common mental health problem. It can cause a persistent feeling of sadness and loss of...
    22 一月 2021
  • Pharmacological interventions for self‐harm in adults Cochrane authors have reviewed the international literature regarding pharmacological (drug) and natural product (dietary supplementation) treatment trials in the field. A total of seven trials that met inclusion criteria were identified. There is little evidence of beneficial effects of either...
    14 一月 2021
  • Two hosts of the podcast, side profiles
    'Let's talk e-cigarettes'' is a podcast talking about the latest research on e-cigarettes and how new research changes what we know about them. It's hosted by Cochrane Tobacco Addiction researchers Dr Jamie Hartmann-Boyce and Dr Nicola Lindson based at the University of Oxford, through funding from Cancer Research UK. You can listen to the podcast...
    12 一月 2021
  • A female frontline worker wears PPE including cap, face shield, mask and gown
    What is the best way to support resilience and mental well-being in frontline healthcare professionals during and after a pandemic? What is ‘resilience’? Updated Jan 2021: Listen to lead author Alex Pollock from Glasgow Caledonian University in Scotland explain what the review found. Updated Dec 2020: new brief for health systems planners and...
    8 一月 2021
  • A metal magnifying glass leans against a stack of papers
    In this short interview, PhD student Camilla Hansen Nejstgaard,  from Cochrane Denmark and Centre for Evidence-Based Medicine Odense (CEBMO) at the University of Southern Denmark, tells us about how conflicts of interest may impact on recommendations of drugs and medical devices. She is the lead author of a recently published Cochrane Methodology...
    5 一月 2021
  • Cochrane Logo
    The Cochrane review about antenatal steroids for reducing risk of infant mortality and morbidity is an important one in Cochrane's history. Cochrane's logo is based on the forest plot from an early version of this review dating back to 1982. This review has recently been updated and lead author, Fiona Stewart, tells us how the logo might look now...
    29 十二月 2020
  • Wearing Cochrane evidence: a personal story of impact
    Rebecca Selby, a mum of four, shares how a Cochrane Review impacted her family. When I unexpectedly went into premature labour with our second son at a little under 32 weeks' gestation, I was given steroid injections to give his lungs the best possible chance in the outside world. George spent almost a month in intensive care when he was born,...
    29 十二月 2020
  • Doctor at desk smiling
    Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews A stillbirth is generally defined as the death of a baby before birth, at or after 24 weeks of development. It is most common in low‐ and middle‐income countries but also affects people in high‐income countries. Numbers of...
    23 十二月 2020
  • Cochrane has expanded its response to COVID-19 by publishing two rapid scoping reviews about care bundles in the intensive care unit (ICU) and measures implemented in schools to contain the SARS-CoV-2 virus. Both reviews were commissioned by the World Health Organisation to inform their guidance. The reviews serve as exemplars for how similar...
    22 十二月 2020
  • Read this recently published Cochrane review about CFTR correctors, a therapy for cystic fibrosis targeted at specific variants (most commonly F508del) In this review, the authors looked at drugs (or drug combinations) for correcting the basic defect in the most common cystic fibrosis (CF)-causing gene variant (F508del) and assessed their impact...
    17 十二月 2020